Our school collaboration project has opened unexpected doors for Eivind.
Norwegian government to double the number of clinical studies.
Dehns acquires Norwegian Intellectual Property consultancy Leogriff.
Ultimovacs has announced a new clinical study targeted at patients with ovarian cancer.
CONNECT is a completely new public-private collaboration in cancer precision medicine.
Read a selection of our news from 2020.